10G Revolve HydroMARK T3 Marker Overview
Authorized Mammotome breast biopsy marker supplier. The 10G Revolve HydroMARK T3 marker, part number 4010-03-09-T3, places a titanium and hydrogel site marker at the moment of biopsy. It is designed for the Mammotome Revolve system and delivers through the probe. Therefore clinicians mark the sampled site quickly and accurately.
This marker is built for long-term follow-up. Its exclusive hydrogel technology supports ultrasound visibility up to 12 months, even after neoadjuvant chemotherapy. In addition, the marker shows a unique anechoic appearance under ultrasound and stays visible on mammography and during an MRI T2 sequence. As a result, care teams can plan localization and surgery with confidence.
Need pricing? Get a quote with lead times within one business day.
Features of the HydroMARK T3 Site Marker
The HydroMARK T3 marker combines a durable titanium core with an exclusive hydrogel carrier. Because of this pairing, it offers clear, lasting visibility across every breast imaging modality.
The HydroMARK marker uses an exclusive hydrogel carrier for long-term ultrasound visibility. Therefore the site stays easy to find during follow-up.
Under ultrasound, the marker shows a unique anechoic appearance. As a result, it provides a clear target for your preferred localization approach. In addition, ultrasound visibility lasts up to 12 months, even after neoadjuvant chemotherapy.
A titanium marker sits inside the hydrogel carrier. Because titanium is dense, the marker remains distinguishable under mammography.
The marker is also easily seen under MRI during a T2 sequence. Consequently, one marker supports ultrasound, mammography, and MR follow-up without a modality change.
See how the HydroMARK T3 marker compares to a generic metallic-only site marker.
The T3 marker deploys through a 10 gauge probe, so it fits directly into the Mammotome Revolve biopsy workflow. In addition, an MRI applicator delivers the marker through an MRI introducer when needed.
Full Specifications
Every specification below comes directly from the Mammotome HydroMARK marker documentation for part number 4010-03-09-T3.
| Marker material | Titanium |
| Carrier | Hydrogel |
| Shape code | T3 |
| Gauge | 10 gauge |
| Family | HydroMARK |
| Ultrasound | Up to 12 months |
| Ultrasound appearance | Unique anechoic |
| MRI | Visible on T2 sequence |
| Mammography | Distinguishable titanium |
| 10G delivery | Through the probe |
| MRI delivery | Through MRI introducer |
| Carrier technology | Exclusive hydrogel |
| Mammotome system | Revolve |
| Bard devices | EnCor Enspire (10G) |
| MR probe | EnCor Enspire MR probe |
| Indication | Axillary lymph nodes and breast tissue |
| Brand | Mammotome |
| Part number | 4010-03-09-T3 |
| Manufacturer | Devicor Medical Products, Inc. |
Clinical Applications
The HydroMARK T3 marker supports the full breast biopsy pathway. Here are six situations where it fits.
Deploy the marker through the 10 gauge Revolve probe. Because it delivers through the probe, the site is marked during the same procedure.
The marker appears anechoic under ultrasound. Therefore clinicians relocate the biopsy site clearly during follow-up scans.
Ultrasound visibility lasts up to 12 months, even after neoadjuvant chemotherapy. As a result, teams track the site through treatment.
The titanium marker is easily seen during an MRI T2 sequence. In addition, an MRI applicator supports MR-guided placement.
The marker is indicated for axillary lymph nodes and breast tissue. Consequently, it supports node marking within one workflow.
A clearly visible marker helps guide localization before surgery. Therefore the surgical team plans excision around a defined target.
The HydroMARK T3 Biopsy Marking Workflow
This marker moves with the patient through each stage of the breast care pathway. The steps below outline a typical workflow.
During a vacuum-assisted biopsy, the marker delivers through the 10 gauge probe. Because deployment happens in the same session, no separate device is needed. The titanium and hydrogel marker settles at the sampled site.
Right after deployment, the marker shows a unique anechoic appearance under ultrasound. Therefore the clinician confirms placement before the patient leaves the room.
Over the following months, the hydrogel carrier keeps the site visible. Ultrasound visibility lasts up to 12 months, even after neoadjuvant chemotherapy. As a result, the care team tracks the lesion throughout treatment.
The titanium marker stays distinguishable under mammography and is easily seen during an MRI T2 sequence. Consequently, follow-up imaging can switch modalities without losing the target.
When surgery is planned, the visible marker helps guide localization. In addition, its clarity supports the team as they define the excision target.
Regulatory and Quality Information
Please review the notes below before ordering. They reflect the manufacturer documentation for this marker.
Use this marker according to the Mammotome Instructions for Use. For complete product details, always refer to the current IFU supplied with the device.
The indication may not be approved or available in every region. Therefore confirm local availability and approved indications with your Mammotome representative.
HydroMARK and Mammotome Revolve are registered trademarks of Devicor Medical Products, Inc. The marker is manufactured by Devicor Medical Products, Inc.
Medical Outfitters Inc. is an ISO 13485:2016 certified medical imaging equipment supplier based in Miami, FL. As a result, we manage sourcing, documentation, and delivery under a controlled quality management system.
How to order
Request pricing and availability on the 10G Revolve HydroMARK T3 marker, part number 4010-03-09-T3, from Medical Outfitters Inc. We confirm compatibility and lead time before you buy.
Product support
Our team helps match the correct HydroMARK part number to your Revolve or compatible biopsy system. Call (305) 885-4045 for assistance.
Frequently Asked Questions
Common questions about the Mammotome 10G Revolve HydroMARK T3 marker, part number 4010-03-09-T3.
It is a titanium and hydrogel breast biopsy site marker. Furthermore, it deploys through a 10 gauge probe for the Mammotome Revolve system.
The marker uses a titanium core inside an exclusive hydrogel carrier. Because of this design, it stays visible across imaging modalities.
Ultrasound visibility lasts up to 12 months. In addition, it remains visible even after neoadjuvant chemotherapy.
Yes. The titanium marker is easily seen during an MRI T2 sequence, and it stays distinguishable under mammography.
It works with the Mammotome Revolve system through the probe. Moreover, the source lists compatibility with Bard EnCor Enspire 10G devices, including the EnCor Enspire MR probe.
The T3 code identifies a specific HydroMARK marker shape configuration. Therefore always confirm the exact part number, 4010-03-09-T3, when ordering.
Yes. The marker is indicated for axillary lymph nodes and breast tissue. However, please confirm approved indications in your region.
You can buy it from Medical Outfitters Inc., an ISO 13485:2016 certified supplier in Miami, FL. Call (305) 885-4045 to order or request a quote.
Compatible Equipment
Explore related breast biopsy markers and devices available from Medical Outfitters Inc.
Request a Quote Today
Get in touch with Medical Outfitters today to request your personalized quote and outfit your facility with confidence.
Related Products
Mammotome MammoMARK MMK1001 Bowtie Biopsy Site Identifier, Titanium Collagen Marker, CS10
Mammotome HydroMARK 10G Flexible Side-Deploy Applicator, PN 4010-05-10-T4
Mammotome Elite MEP10 10 ga Probe with Cannula Included, CS5
